Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain
dc.conference.date | SEP 16-21, 2021 | |
dc.conference.title | Congress of the European-Society-for-Medical-Oncology (ESMO) | |
dc.contributor.author | Ortega Granados, A. L. | |
dc.contributor.author | Rojo Todo, F. | |
dc.contributor.author | Alvarez Alvarez, R. | |
dc.contributor.author | Majem Tarruella, M. | |
dc.contributor.author | Ruiz de Alda Iparraguirre, L. | |
dc.contributor.author | Garcia Verdes-Montenegro, J. F. | |
dc.contributor.author | Gordo Flores, R. | |
dc.contributor.author | Gonzalez-Dominguez, A. | |
dc.contributor.author | Ivanova Markova, Y. | |
dc.contributor.author | Sanchez San Cristobal, R. | |
dc.contributor.authoraffiliation | [Ortega Granados, A. L.] Complejo Hosp Jaen, Med Oncol, Jaen, Spain | |
dc.contributor.authoraffiliation | [Rojo Todo, F.] Hosp Univ Fdn Jimenez Diaz, Pathol Anat, Madrid, Spain | |
dc.contributor.authoraffiliation | [Alvarez Alvarez, R.] Hosp Gregorio Maranon, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Majem Tarruella, M.] Hosp Santa Creu & Sant Pau, Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Ruiz de Alda Iparraguirre, L.] Roche, Corp Affairs, Madrid, Spain | |
dc.contributor.authoraffiliation | [Garcia Verdes-Montenegro, J. F.] Roche, Dept Med, Madrid, Spain | |
dc.contributor.authoraffiliation | [Gordo Flores, R.] Roche, Dept Med, Madrid, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Dominguez, A.] Weber, Pharmacoecon & Market Access, Madrid, Spain | |
dc.contributor.authoraffiliation | [Ivanova Markova, Y.] Weber, Pharmacoecon & Market Access, Madrid, Spain | |
dc.contributor.authoraffiliation | [Sanchez San Cristobal, R.] Weber, Pharmacoecon & Market Access, Madrid, Spain | |
dc.contributor.funder | Roche | |
dc.date.accessioned | 2025-01-07T14:40:36Z | |
dc.date.available | 2025-01-07T14:40:36Z | |
dc.date.issued | 2021-09-21 | |
dc.identifier.doi | 10.1016/j.annonc.2021.08.1809 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.annonc.2021.08.1809 | |
dc.identifier.uri | https://hdl.handle.net/10668/26580 | |
dc.identifier.wosID | 700527702223 | |
dc.issue.number | 5 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario de Jaén | |
dc.page.number | S960-S960 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 32 | |
dc.wostype | Meeting Abstract |